Summary
An overview is presented on progress made in research on 5-HT1A receptors and their ligands since their discovery in 1983. Molecular biology has offered new tools, for example cloned 5-HT1A receptors, their mutants and chimeras to study structure and function. Many compounds, belonging to different chemical classes, display high affinity and selectivity for 5-HT1A receptors. The majority of these compounds are agonists or partial agonists, full antagonists are still scarce. Agonists and partial agonists are active in various animal models of anxiety and depression. Partial receptor agonists have been proven to be effective in general anxiety disorder and depression in man. Potential therapeutic applications for 5-HT1A receptor antagonists are evaluated, for example, in cognition disorders.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Abbreviations
- 5-HT:
-
5-hydroxytryptamine (serotonin)
- 8-OH-DPAT:
-
8-hydroxy-2-(di-n-propylamino)tetralin
- SSRI:
-
selective serotonin reuptake inhibitors
- 5-HTT:
-
5-HT transporter
- TM:
-
transmembrane domain
- IA:
-
intrinsic activity
- DRL 72 s:
-
differential reinforcement of low rates – 72 seconds.
References
Erspamer V.: Arch. Exp. Pathol. Pharmacol. 196, 336–390 (1940).
Rapport M.M.: J. Biol. Chem. 180, 961–969 (1949).
Erspamer V. and Asero N.: Nature 169, 800–801 (1952).
Bertacinni G. and Chieppa S.: Lancet 1, 881 (1960).
Farthing M.J.G.: Scand. J. Gastroenterol. 26, 92–100 (1991).
Grahame-Smith D.G.: Quart. J. Med. 67, 459–466 (1988).
Twarag B.M. and Page LH.: Am. J. Physiol. 174, 157–161 (1953).
Wooley D.W. and Shaw E.: Proc. Natl. Acad. Sci. 40, 228–231 (1954).
Steinbush H.W.M.: Neurosci. 4, 557–618 (1981).
Peroutka SJ. and Snyder S.H.: Mol. Pharmacol. 16, 687–695 (1979).
Jacobs B.L. and Azmitia E.C.: Physiol. Rev. 72, 165–229 (1992).
Törk L: Ann. NY Acad. Sci. 600, 6–35 (1990).
Molliver M.E., Berger U.V., Mamounas L.A., Molliver D.C., O’Hearn E. and Wilson M.A.: Ann. NY Acad. Sci. 600, 640–664 (1990).
Holstege G.: Progr. Brain Res. 87, 307–412 (1991).
Holstege J.C., in: G. Holstege, R. Bandler and C. Saper (eds.): The Emotional Motor System. Elsevier, Amsterdam 1996, 159–182.
Pazos A. and Palacios J.M.: Brain Res. 346, 205–230 (1985).
Vergé D., Daval G., Marcikiewicz M., Patey A., El Mestikawy S., Gozlan H. and Hamon M.: J. Neurosci. 6, 3474–3482 (1986).
Gardier A.M., Malagrié I., Trillat A.C., Jacquot C. and Artigas F.: Fundam. Clin. Pharmacol. 10, 16–27 (1996).
Bosker F.J., De Winter T.Y.C.E., Klompkamers A.A. and Westenberg H.G.M.: J. Neurochem. 66, 2546–2555 (1996).
Chopin P., Moret C. and Briley M.: Pharmacol. Ther. 62, 385–405 (1994).
Hrdina P.D., Foy B., Hepner A., Summers R.J.: J. Pharmacol. Exp. Therap. 252, 410–418 (1990).
Pedigo N.W., Yamamura H.I. and Nelson D.L.: J. Neurochem. 36, 220–226 (1981).
Middlemiss D.N. and Fozard J.R.: Eur. J. Pharmacol. 90, 151–153 (1983).
Gozlan H., El Mestikawy S., Pichat L., Glowinski J. and Hanson M.: Nature 304, 140–142 (1983).
Pompeiano M., Palacios J.M. and Mengod G.: J. Neurosci. 12, 440–453 (1992).
Miquel M.C., Doucet E., Boni C., El Mestikawy S., Matthiessen L., Daval G., Vergé D. and Hamon M.: Neurochem. Int. 19, 453–465 (1991).
Chalmers D.T. and Watson S.J.: Brain Res. 561, 51–60 (1991).
Riad M., El Mestikawy S., Vergé D., Gozlan H. and Hamon M.: Neurochem. Int. 19, 413–423 (1991).
Radja F., Daval G., Hamon M. and Vergé D.: J. Neurochem. 58, 1338–1346 (1992).
Vergé D., Daval G., Patey A., Gozlan H., El Mestikawy S. and Hamon M.: Eur. J. Pharmacol. 113, 463–464 (1985).
Weissmann-Nanopoulos D., Mach E., Magre J., Demassey Y. and Pujol J.-F.: Neurochem. Int. 7, 1061–1072 (1985).
Sotelo C., Cholley B., El Mestikawy S., Gozlan H. and Hamon M.: Eur. J. Neurosci. 2, 1144–1154 (1990).
Lima L., Laporte A.-M., Gaymard C., Spedding M., Mocaër E. and Hamon M.: J. Neural Transmission 104, 1059–1075 (1997).
Sundaram H., Turner J.D. and Strange P.G.: J. Neurochem. 65, 1909–1916 (1995).
Newman-Tancredi A., Conte C., Chaput C., Verrièle L. and Millan M.J.: Neuropharma-cology 36, 451–459 (1997).
Khawaja X., Evans N., Reilly Y., Ennis C. and Minchin M.C.W.: J. Neurochem. 64, 2716–2726 (1995).
Khawaja X., Ennis C. and Minchin M.C.W.: Life Sci 60, 653–665 (1997).
Khawaja X.: Brain Res. 673, 217–225 (1995).
Gozlan H., Thibault S., Laporte A.M., Lima L. and Hamon M.: Eur. J. Pharmacol. (Mol. Pharmacol. sect.) 288, 173–186 (1995).
Hall H., Lundkvist C., Halldin C., Farde L., Pike V.W., McCarron J.A., Fletcher A., Cliffe I.A., Barf T., Wikström H. and Sedvall G.: Brain Res. 745, 96–108 (1997).
Burnet P.W., Eastwood S.L. and Harrison P.J.: Neurochem. Int. 30, 565–574 (1997).
Pike V.W., McCarron J.A., Lammertsma A.A., Fletcher S.P., Poole K., Grasby P.M., Malizia A., Cliffe I.A., Fletcher A. and Bench C.J.: Eur. J. Pharmacol. 283, R1–R3 (1995).
Osman S., Lundkvist C., Pike V.W., Halldin C., McCarron J.A., Swahn C.-G., Ginovart N., Luthra S.K., Bench C.J. and Grasby P.M.: Nuclear Medicine Biol. 23, 627–634 (1996).
Pike V.W., McCarron J.A., Lammertsma A.A., Osman S., Hume S.P., Sargent P.A., Bench C.J., Cliffe I.A., Fletcher A. and Grasby P.M.: Eur. J. Pharmacol. 301, R5–R7 (1996).
Zhuang Z.-P., Kung M.-P., Mu M., Kung H.F.: J. Med. Chem. 41, 157–166 (1998).
Kobilka B.K., Frielle T., Collins S., Yang-Feng T., Kobilka T.S., Francke U., Lefkowitz R.J. and Caron M.G.: Nature 329, 75–79 (1987).
Fargin A., Raymond J.R., Lohse M.J., Kobilka B.K., Caron M.G. and Lefkowitz R.J.: Nature 335, 358–360 (1988).
Albert RR., Zhou Q.-Y., Van Tol H.H.M., Bunzow J.R. and Civelli O.: J. Biol. Chem. 265, 5825–5832 (1990).
Chanda P.K., Minchin M.C.W., Davis A.R., Greenberg L., Reilly Y., McGregor W.H., Bhat R., Lubeck M.D., Mizutani S. and Hung P.P.: Mol. Pharmacol. 43, 516–520 (1993).
Andrade R., Malenka R.C. and Nicoll R.A.: Science 234, 1261–1265 (1986).
Ho B.Y., Karschin A., Branchek Th., Davidson N. and Lester H.A.: FEBS Lett 312, 259–262 (1992).
Kuipers W., Van Wijngaarden I., Kruse C.G., Ter Horst-Van Amstel M., Tulp M.Th.M. and IJzerman A.P.: J. Med. Chem. 38, 1942–1954 (1995).
Guan X.-M., Peroutka S.J. and Kobilka B.K.: Mol. Pharmacol. 41, 695–698 (1992).
Kuipers W., Link R., Standaar P.J., Stoit A.R., Van Wijngaarden I., Leurs R. and IJzerman A.P.: Mol. Pharmacol. 51, 889–896 (1997).
Grånës Ch., Nordvall G. and Larhammar D.: Eur. J. Pharmacol. 349, 367–375 (1998).
Sprang S.R.: Ann. Rev. Biochem. 66, 639–678 (1997).
Rens-Domiano S. and Hamm H.E.: FASEB J. 9, 1059–1066 (1995).
Gudermann Th., Kalkbrenner F. and Schultz G.: Ann. Rev. Pharmacol. Toxicol. 36, 429–459 (1996).
Kjeldgaard M., Nyborg J. and Clark B.F.C.: FASEB J. 10, 1347–1368 (1996).
Neer E.J.: Cell 80, 249–257 (1995).
Kaziro Y., Itoh H., Kozasa T., Nakafuka M. and Satoh T.: Ann. Rev. Biochem. 60, 349–400 (1991).
Varrault A., Le Nguyen D., McClue S., Harris B., Jouin P. and Bockaert J.: J. Biol. Chem. 269, 16720–16725 (1994).
Lembo P.M.C., Ghahremani M.H., Morris S.J. and Albert RR.: Mol. Pharmacol. 52, 164–171 (1997).
Medina R., Grishina G., Meloni E.G., Muth Th.R. and Berlot C.H.: J. Biol. Chem. 271, 24720–24727 (1996).
Grishina G. and Berlot C.H.: J. Biol. Chem. 272, 20619–20626 (1997).
Sunahara R.K., Dessauer C.W. and Gilman A.G.: Ann. Rev. Pharmacol. Toxicol. 36, 461–480 (1996).
Taussig R., Tang W.-J., Hepler J.R. and Gilman A.G.: J. Biol. Chem. 269, 6093–6100 (1994).
Taussig R. and Gilman A.G.: J. Biol. Chem. 270, 1–4 (1995).
Houslay M.D. and Milligan G.: TIBS 22, 217–224 (1997).
Skiba N.P. and Hamm H.E.: Nature Struct. Biol. 5, 88–92 (1998).
Zimmermann G., Zhou D. and Taussig R.: J. Biol. Chem. 273, 19650–19655 (1998).
Varga E.V., Stropova D., Rubenzik M., Wang M., Roeske W.R. and Yamamura H.I.: Eur. J. Pharmacol. 348, R1–R2 (1998).
Nelson D.L.: Pharmacol. Biochem. Behav. 40, 1041–1051 (1991).
Glennon R.A.: Drug Dev. Res. 26, 251–274 (1992).
Cliffe I.A. and Fletcher A.: Drugs Future 7, 631–642 (1993).
Boess EG. and Martin I.L.: Neuropharmacology 33, 275–317 (1994).
Fletcher A., Cliffe I.A. and Dourish C.T.: TIPS 14, 441–448 (1993).
Van Wijngaarden I., Tulp M.Th.M. and Soudijn W: Eur. J. Pharmacol. — Mol. Pharmacol. Sect. 188, 301–312 (1990).
Liu Y., Yu H., Svensson B.E., Cortizo L., Lewander T. and Hacksell U.: J. Med. Chem. 36, 4221–4229 (1993).
Romero A.G., Leiby J.A., McCall R.B., Piercey M.F., Smith M.W. and Han F.: J. Med. Chem. 36, 2066–2074 (1993).
Stjernlöf P., Gullme M., Elebring T., Anderson B., Wikström H., Lagerquist S., Svensson K., Ekman A., Carlsson A. and Sundeil S.: J. Med. Chem. 36, 2059–2065 (1993).
Stjernlöf P., Elebring T., Nilsson J., Andersson B., Lagerkvist S., Svensson K., Ekman A., Carlsson A. and Wikström H.: J. Med. Chem. 37, 3263–3273 (1994).
Stjernlöf P., Ennis M.D., Hansson L.O., Hoffman R.L., Ghazal N.B., Sundell S., Smith M.W., Svensson K., Carlsson A. and Wikström H.: J. Med. Chem. 38, 2202–2216 (1995).
Björk L., Höök B.B., Nelson D.L., Andén N.E. and Hacksell U.: J. Med. Chem. 32, 779–783 (1989).
Naiman N., Lyon R.A., Bullock A.E., Rydelek L.T., Titeler M. and Glennon R.A.: J. Med. Chem. 32, 253–256 (1989).
Glennon R.A., Naimann N.A., Pierson M.E., Smith J.D., Ismaiel A.M., Titeler M. and Lyon R.A.: J. Med. Chem. 32, 1921–1926 (1989).
Podona T., Guardiola-Lemaitre B-, Caignard D.-H., Adam G., Pfeiffer B., Renard P. and Guillaumet G.: J. Med. Chem. 37, 1779–1793 (1994).
Hibert M.F., McDermott I., Middlemiss D.N., Mir A.K. and Fozard J.R.: J. Med. Chem. 24, 31–37 (1989).
Hillver S.-E., Björk L., Li Y.L., Svensson B., Ross A., Andén N.E. and Hacksell U.: J. Med. Chem. 33, 1541–1544 (1990).
Backlund Höök B., Cortizo L.; Johansson A.M., Westlind-Danielsson A., Mohell N. and Hacksell U.: J. Med. Chem. 39, 4036–4043 (1996).
Johansson L., Sohn D., Thorberg S.-O., Jackson D.M., Kelder D., Larsson L.-G., Rényi L., Ross S.B., Wallsten C., Eriksson H. et al.: J. Pharmacol. Exp. Therap. 283, 216–225 (1997).
Liu Y., Mellin C., Bjork L., Svensson B., Csoregh I., Helander A., Kenne L., Andén N.E. and Hacksell U.: J. Med. Chem. 32, 2311–2318 (1989).
Mellin C., Vallgårda J., Nelson D.L., Björk L., Yu H., Andén N.E., Csöregh I., Arvidsson LE. and Hacksell U.: J. Med. Chem. 34, 497–510 (1991).
Liu Y., Yu H., Mohell N., Nordvall G., Lewander T. and Hacksell U.: J. Med. Chem. 38, 150–160 (1995).
Lin C.H., Haadsma-Svensson S.R., Lathi R.A., McCall R.B., Piercey M.F., Schreur P.J.K.D., Von Voigtlander P.F., Smith M.W. and Chidester CG.: J. Med. Chem. 36, 1053–1068 (1993).
Chidester C.G., Lin C.-H., Lathi R.A., Haadsma-Svensson S.R. and Smith M.W.: J. Med. Chem. 36, 1301–1315 (1993).
Wikström H., Andersson B., Elebring T., Jacyno J., Allinger N.L., Svensson K., Carlsson A. and Sundell S.: J. Med. Chem. 30, 1567–1573 (1987).
Lin C.H., Haadsma-Svensson S.R., Philips G., Lathi R.A., McCall R.B., Piercey M.F., Schreur P.J.K.D., Von Voigtlander P.F., Smith M.W. and Chidester C.G.: J. Med. Chem. 36, 1069–1083 (1993).
Comoy C., Marot C., Podona T., Baudin M.-L., Morin-Allory L., Guillaumet G., Pfeiffer B., Caignard D.-H., Renard P. et al.: J. Med. Chem. 39, 4285–4298 (1996).
Hoyer D. and Schoefter P.: J. Rec. Res. 11, 197–214 (1991).
Hoyer D., in: J.R. Fozard (ed.): The peripheral actions of 5-hydroxytryptamine. Oxford University Press, New York 1989, 72–99.
Dahlgren T., Dean R.L., Gharat L.A., Johansson A.M., Lambert G., Li H.B., Nelson D.L., Yang Y. and Martin A.R.: Bioorg. Med. Chem. Lett. 5, 2963–2968 (1995).
Newman-Tancredi A., Conte C., Chaput C., Verriète L., Audinot-Bouchez V., Lochon S., Lavielle G. and Millan M.J.: Naunyn-Schmiedeberg’s Arch. Pharmacol. 355, 682–688 (1997).
Mantegani S., Brambilla E., Caccia C., Damiani G., Fornaretto M.G., McArthur R.A. and Varasi M.: Bioorg. Med. Chem. Lett. 8, 1117–1122 (1998).
Slaughter J.L., Harrington M.A. and Peroutka S.J.: Life Sci. 47, 1331–1337 (1990).
Foreman M.M., Fuller R.W., Leander J.D., Benvenga M.J., Wong D.T., Nelson D.L., Calligaro D.O., Swanson S.P., Lucot J.B. and Flaugh M.C.: J. Pharmacol. Exp. Therap. 267, 58–71 (1993).
Cannon J.G., Mohan P., Bojarski J., Long J.P., Bhatnagar R.K., Leonard P.A., Flynn J.R. and Chatterjee T.K.: J. Med. Chem. 31, 313–318 (1988).
Cannon J.G., Moe S.T. and Long J.P.: Chirality 3, 19–23 (1991).
Cannon J.G., Flaherty P.T., Ozkutlu U. and Long J.P.: J. Med. Chem. 38, 1841–1845 (1995).
Westkaemper R.B. and Glennon R.A.: Pharmacol. Biochem. Behav. 40, 1019–1031 (1991).
Hedberg M.H., Johansson A.M., Nordvall G., Yliniemelä A., Li H.B., Martin A.R., Hjörth S., Unelius L., Sundell S. and Hackseil U.: J. Med. Chem. 38, 647–658 (1995).
Hedberg M.H., Linnanen T., Jansen J.M., Nordvall G., Hjörth S., Unelius L. and Johansson A.M.: J. Med. Chem. 39, 3503–3513 (1996).
Cannon J.G., Jackson H., Long J.P., Leonard P. and Bhatnager R.K.: J. Med. Chem. 32, 1959–1962 (1989).
Yocca F.D., Smith D.W., Hyslop D.K. and Maayani S.: Soc. Neurosci. Abstr. 12, 422 (1986).
De Vivo M. and Maayani S.: J. Pharmacol. Exp. Ther. 238, 248–253 (1986).
Löscher W., Witte U., Fredow G., Traber J. and Glaser T.: Naunyn-Schmiedeberg’s Arch. Pharmacol. 342, 271–277 (1990).
Hamik A., Oksenberg D., Fischette C. and Peroutka S.J.: Biol. Psychiatry 28, 99–109 (1990).
Abou-Gharbia M., Patel U.R., Webb M.B., Moyer J.A., Andree T.H. and Muth E.A.: J. Med. Chem. 31, 1382–1392 (1988).
Yocca F.D., Hyslop D.K., Smith D.W. and Maayani S.: Eur. J. Pharmacol. 137, 293–294 (1987).
LĂłpez-RodrĂguez M.L., Rosado L., BenhamĂş B., Morcillo M.J., Sanz A.M., Orensanz L., Beneitez E., Fuentes J.A. and Manzanares J.: J. Med. Chem. 39, 4439–4450 (1996).
Beneytez M.E., López-Ródriguez M.L.., Rosado M.L., Morcillo M.J., Orensanz L., Fuentes J.A. and Manzanaris J.: Eur. J. Pharmacol. 344, 127–135 (1998).
LĂłpez-RodrĂguez MX., Morcillo M.J., Rovat T.K., Fernández E., Sanz A.M. and Orensanz L.: Bioorg. Med. Chem. Lett. 8, 581–586 (1998).
El-Bermawy M., Raghupathi R., Ingher S.P., Teitler M., Maayani S. and Glennon R.A.: Med. Chem. Res. 2, 88–95 (1992).
Kuipers W., Kruse C.G., Van Wijngaarden I., Standaar P.J., Tulp M.Th.M., Veldman N., Spek AX. and IJzerman A.P.: J. Med. Chem. 40, 300–312 (1997).
Fletcher A., Bill D.J., Bill S.J., Cliffe I.A., Dover G.M., Foster E.A., Haskins J.T., Jones D., Mansell HX. and Reilly Y.: Eur. J. Pharmacol. 237, 283–291 (1993).
Corradetti R., Laaris N., Hanoun N., Laporte A.M., Le Poul E., Hamon M. and Lanfumey L.: Br. J. Pharmacol. 123, 449–462 (1998).
Cliffe I.A., Brightwell C.I., Fletcher A., Forster E.A., Mansell H.L., Mansell Y.R., Routledge C. and White A.C.: J. Med. Chem. 36, 1509–1510 (1993).
Mos J., Van Hest A., Van Drimmelen M., Herremans A.H.J. and Olivier B.: Eur. J. Pharmacol. 325, 145–153 (1997).
Newman-Tancredi A., Chaput C., Verrièle L. and Millan M.J.: Eur. J. Pharmacol. 307, 107–111 (1996).
Van Steen B.J., Van Wijngaarden I., Ronken E. and Soudijn W.: Bioorg. Med. Chem. Lett. 8, 2457–2462 (1998).
Colpaert F.C., Koek W., Lehmann J., Rivet J.M., Lejeune F., Canton H., Bervoets K., Millan M.J., Laubie M. and Lavielle G.: Drug Dev. Res. 26, 21–48 (1992).
El Ahmad Y., Laurent E., Maillet P., Talab A., Teste J.F., Dokhan R., Tran G. and Ollivier R.: J. Med. Chem. 40, 952–960 (1997).
Schoeffter P., Fozard J.R., Stoll A., Siegl H.; Seiler M.P. and Hoyer D.: Eur. J. Pharmacol. Mol. Pharmacol. Sect. 244, 251–257 (1993).
Lanfumey L., Haj-Dahmane S. and Hamon M.: Eur. J. Pharmacol. 249, 25–35 (1993).
Modica M., Santagati M., Russo F., Parotti L., De Gioia L., Selvaggini C., Salmona M. and Mennini T.: J. Med. Chem. 40, 574–585 (1997).
Taverne T., Diouf O., Depreux P., Poupart J.H., Lesieur D., Guardiola-Lemaitre B., Renard P., Rettori M.C., Caignard D.H. and Pfeiffer B.: J. Med. Chem. 41, 2010–2018 (1998).
Reitz A.B., Baxter E.W., Codd E.E., Davis C.B., Jordan A.D., Maryanoff B.E., Maryanoff CA., McDonnel M.E., Powel E.T., Renzi M.J. et al.: J. Med. Chem. 41, 1997–2009 (1998).
Baxter E.W. and Reitz A.B.: Bioorg. Med. Chem. Lett. 7, 763–768 (1997).
Glennon R.A., Naiman N.A., Lyon R.A. and Titeler M.: J. Med. Chem. 31, 1968–1971 (1988).
Huff J.R., King S.W., Saari WS., Springer J.P., Martin G.E. and Williams M.: J. Med. Chem. 28, 945–948 (1985).
Mátyus P., Varga I., Zára E., Mezei A., Behr A., Simay A., Haider N., Boros S., Bakonyi A., Horváth E. et al.: Bioorg. Med. Chem. Lett. 7, 2857–2862 (1997).
Dabire H., Bajjou R., Chaouche-Teyara K., Fournier B., De Nanteuil G., Laubie M., Safar M. and Schmitt H.: Eur. J. Pharmacol. 203, 323–324 (1991).
Yasunaga T., Naito R., Kontani T., Tsukamoto S., Nomura T., Yamaguchi T. and Mase T.: J. Med. Chem. 40, 1252–1257 (1997).
Yasunaga T., Kimura T., Naito R., Kontani T., Wanibuchi F., Yamashita H., Nomura T., Tsukamoto S., Yamaguchi T. and Mase T.: J. Med. Chem. 41, 2765–2778 (1998).
Pierson M.E., Lyon R.A., Titeler M., Kowalski P. and Glennon R.A.: J. Med. Chem. 32, 859–863 (1989).
De Vry J., Schohe-Loop R., Heine H.-G., Greuel J.M., Mauler F., Schmidt B., Sommermeyer H. and Glaser T.: J. Pharmacol. Exp. Ther. 284, 1082–1094 (1998).
Hibert M. and Moser P.: Drugs Future 15, 159–170 (1990).
Matsuda T., Yoshikawa T., Suzuki M., Asano S., Somboonthum P., Takuma K., Nakano Y., Morita T., Nakase Y., Sun Kim H. et al.: Jap. J. Pharmacol. 69, 357–366 (1995).
Nikam S.S., Martin A.R. and Nelson D.L.: J. Med. Chem. 31, 1965–1968 (1988).
Schoeffter P. and Hoyer D.: Br. J. Pharmacol. 95, 975–985 (1988).
Langlois M., Brémont B., Rouselle D. and Gaudy F.: Eur. J. Pharmacol. 244, 77S7 (1993).
Prisco S., Cagnotto A., Talone D., De Blasi A., Mennini T. and Esposito E.: J. Pharmacol. Exp. Ther. 265, 739–744 (1993).
Hjorth S. and Sharp T.: J. Pharmacol. Exp. Ther. 265, 707–712 (1993).
Lejeune F., Rivet J.M., Gobert A., Canton H. and Millan M.J.: Eur. J. Pharmacol. 240, 307–310 (1993).
Valgårda J., Appelberg U., Arvidsson L.-E., Hjorth S., Svensson B.E. and Hacksell U.: J. Med. Chem. 39, 1485–1493 (1996).
Raymond J.R.: J. Biol. Chem. 277, 14747–14753 (1991).
Wilkinson L.D. and Dourish C.T., in: SJ. Peroutka (ed.): Serotonin receptor subtypes, basic and clinical aspects. Wiley-Liss Ine, New York 1991, 147–210.
Jacobs B.L.: Life Sci. 19, 777–786 (1976).
Berendsen H.H.G., Jenck F. and Broekkamp C.L.E.: Pharmacol. Biochem. Behav. 33, 821–827 (1989).
Molewijk H.E., Van der Heyden J.A.M. and Olivier B: Eur J. Neurosci. 214 (Suppl. 2), 121–136 (1989).
Berendsen H.H.G., Broekkamp C.L.E. and Van Delft A.M.L.: Eur. J. Pharmacol. 187, 97–10 (1990).
Myers R.D. and Lee T.F., in: L.C.H. Wang (ed.): Advances in environmental and comparative physiology, vol. 4. Springer-Verlag, Berlin 1989, 161–203.
Goodwin G.M. and Green A.R.: Br. J. Pharmacol. 84, 743–753 (1985).
Green A.R. and Goodwin G.M., in: C.T. Dourish, S. Ahlenius and P.H. Hutson (eds.): Brain 5-HT1A Receptors, Behavioural and Neurochemical Pharmacology. Ellis Horwood Ltd., Chichester, U.K. 1987, 161–176.
Millan M.J., Rivet J.M., Canton H., Lejeune F., Gobert A., Widdowson P., Bervoets K., Brocco M. and Peglion J.L.: Eur. J. Pharmacol. 230, 99–102 (1993).
Anderson I.M., Cowen P.J., Grahame-Smith D.G.: Psychopharmacology 100, 498–503 (1990).
Lesch K.P., Mayer S., Disselkamp-Tietze A., Hoh M., Wiesmann M., Osterheider M. and Schulte H.: Biol. Psychiatry 28, 620–628 (1990).
Anderson I.M. and Cowen P.J.: Psychopharmacology 106, 428–432 (1992).
Olivier B., Zethof T.J.J., Ronken E. and Van der Heyden J.A.M.: Eur. J. Pharmacol. 342, 177–182 (1998).
Seletti B., Benkelfat C., Blier P., Annable L., Gilbert F. and de Montigny C.: Neuropsy-chopharmacology 13, 93–104 (1995).
Bill DJ., Knight M., Forster E.A. and Fletcher A.: Br. J. Pharmacol. 103, 1857–1864 (1991).
Levi A.D. and Van de Kar L.D.: Life Sci. 51, 83–94 (1992).
Groenink L., Van der Gugten J., Verdouw P.M., Maes R.A.A. and Olivier B.: Eur. J. Pharmacol. 280, 185–193 (1995).
Korte S.M., Bouws G.A.H., Koolhaas J.M. and Bohus B.: Physiol Behav. 52, 355–361 (1992).
Chaouloff E: Brain Res. Rev. 18, 1–32 (1993).
Groenink L.: 5-HT1A receptors, stress and anxiety — Neuroendocrine and behavioural interrelationships. PhD Thesis, Utrecht 1996, 1-160.
Lesch K.P.: Prog. Neuropsychopharmacol. Biol. Psychiatry 15, 723–733 (1991).
Yatham L.N. and Steiner M.: Life Sci. 53, 447–453 (1993).
Dourish C.T., Hutson P.H. and Curzon G.: Psychopharmacology 86, 197–204 (1985).
Dourish C.T., Hutson P.H. and Curzon G.: Brain Res. Bull. 15, 377–384 (1985).
Blundell J.E.: Int. J. Obesity 1, 15–42 (1977).
Ahlenius S., Larsson K., Svensson L., Hjorth S., Carlsson A.: Pharmacol. Biochem. Behav. 15, 785–792 (1981).
Glaser T., Dompers W.U., Schuurman T., Spencer D.G. Jr. and Traber J., in: C.T. Dourish, S. Ahlenius and P.H. Hudson (eds.): Brain 5-HT1A receptors, Behavioral and Neuro-chemical Pharmacology. Ellis Horwood Ltd., Chichester, U.K. 1987, 106–119.
Haensel S.M. and Slob A.K.: Eur. J. Pharmacol. 330, 1–9 (1997).
Mos J., Olivier B., Bloetjes K. and Poth M., in: A.K. Slob and M.J. Baum (eds.): Psychoneuroendocrinology of growth and development. Medicom, Bussum 1990, 221–232.
Olivier B. and Mos J., in: T. Archer and S. Hansen (eds.): Behavioral biology, neuroendocrine axis. Lawrence Erlbaum Ass, Hillsdale, New Jersey 1991, 207–227.
Amone M., Baroni M., Gai J., Guzzi U., Dexlaux M.F., Keane P.E., Le Fur G. and Soubrié P.: Behav. Pharmacol. 6, 276–282 (1995).
Ahlenius S. and Larsson K., in: C.T. Dourish, S. Ahlenius and P.H. Hutson (eds.): Brain 5-HT1A receptors, Behavioral and Neurochemical Pharmacology. Ellis Horwood Ltd., Chichester, U.K. 1987, 185–198.
Mos J., Van Logten J., Bloetjes K. and Olivier B.: Neurosci. Biobehav. Rev. 15, 505–510 (1991).
Ahlenius S. and Larsson K.: J. Neural Transm. 77, 163–170 (1989).
Coolen L.M., Olivier B., Peters HJ.P.W. and Veening J.G.: Physiol. Behav. 62, 881–891 (1997).
Slangen J.L., in: B. Olivier, J. Mos, J.L. Slangen (eds.): Animal models in psychopharmacology. Birkhäuser Verlag, Basel 1991, 359–379.
Glennon R.A.: Pharmacol. Biochem. Behav. 25, 135–139 (1986).
Ybema C.E., Slangen J.L., Olivier B. and Mos J.: Behav. Pharmacol. 4, 610–624 (1993).
Ybema C.E., Slangen J.L., Olivier B. and Mos J.: Pharmacol. Biochem. Behav. 35, 781–783 (1990).
Nader M.A., Hoffman S.M., Gleeson S. and Barrett J.E.: Behav. Pharmacol. 1, 57–67 (1989).
Schreiber R., Brocco M., Lefèbvre de Ladonchamps B., Monneyron S. and Millan M.: J. Pharmacol. Exp. Ther. 275, 822–831 (1995).
Gommans J., Hijzen TH., Maes R.A.A., Mos J. and Olivier B.: Eur. J. Pharmacol. 284, 135–140 (1995).
Kalkman H.O.: Psychopharmacology 101, 39–42 (1990).
Schreiber R. and De Vri J.: J. Pharmacol. Exp. Ther. 265, 572–579 (1993).
Griebel G.: Pharmacol. Ther. 65, 319–395 (1995).
Zethoff T.J.J., Heyden van der J.A.M., Tolboom J.T.B.M. and Olivier B.: Physiol. Behav. 55, 109 (1994).
Vivian J.A. and Miczek K.A.: Psychopharmacology 104, 187–193 (1991).
Rodgers R.J.: Behav. Pharmacol. 8, 477–496 (1997).
Miczek K.A., Weerts E.M., Vivian J.A. and Barros H.M.: Psychopharmacology 121, 38–56 (1995).
Lister R.G.: Pharmacol. Ther. 46, 321–340 (1990).
Willner P. and Muscat R., in: B. Olivier, J. Mos, J.L. Slangen (eds.): Animal models in psychopharmacology. Birkhäuser Verlag, Basel 1991, 183–198.
Olivier B. and Van der Heyden J.A.M., in: A. Honig, H.M. van Praag (eds.): Depression, Neurobiological, Psychopathological and Therapeutic Advances. John Wiley & Sons, Chichester 1997, 445–457.
De Vry J.M., Schreiber R., Glaser T. and Traber J., in: S.M. Stahl (ed.): Serotonin 1A Receptors in Depression and Anxiety. Raven Press, New York 1992, 55–81.
Geller I. and Seifter J.: Psychopharmacology 9, 482–492 (1960).
Barrett J.E., in: B. Olivier, J. Mos, J.L. Slangen (eds.): Animal Models in Psychopharma-cology. Birkhäuser Verlag, Basel 1991, 37–52.
Vogel J.R., Beer B. and Clody D.E.: Psychopharmacology 21, 1–7 (1971).
Barrett J.E. and Gleeson S., in: R.J. Rodgers and SJ. Cooper (eds.): 5-HT1A agonists; 5-HT3 antagonists and benzodiazepines; their comparative behavioural pharmacology. John Wiley and Sons Ltd, Chichester 1991, 59–105.
Sanger DJ.: J. Pharmacol. Exp. Ther. 254, 420–426 (1990).
Boissier J.R., Simon P. and Aron C: Eur. J. Pharmacol. 4, 145–151 (1968).
Aron C., Simon P. and Boissier J.R.: Neuropharmacologia 10, 459–469 (1971).
Cuomo V., Cagiano R., Da Salvia M.A., Maselli M.A., Renna G. and Racagni G.: Life Sci. 43, 485–491 (1988).
Walsh R.N. and Cummins R.A.: Psychol. Bull. 83, 482–487 (1976).
Hughes R.N.: Psychopharmacology 24, 462–469 (1972).
Handley S.L. and Mithani S.: Naunyn-Schmiedeberg’s Arch. Pharmacol. 327, 1–5 (1984).
File S.E., Andrws N. and Hogg S., in: H.G.M. Westenberg, J.A. Den Boer and D.L. Murphy (eds.): Advances in the Neurobiology of Anxiety Disorders. John Wiley & Sons Ltd, Chichester 1996, 61–79.
Pellow S., Johnston A.L. and File S.E.: J. Pharm. Pharmacol. 39, 917–928 (1987).
Critchley M.A.E. and Handley S.L.: Psychopharmacology 93, 502–506 (1987).
Moser P.C.: Psychopharmacology 99, 48–53 (1989).
Crawley J.N.: Pharmacol. Biochem. Behav. 15, 695–699 (1981).
Kilfoil T., Michel A., Montgomery D. and Whiting R.L.: Neuropharmacology 28, 901–905 (1989).
Carli M. and Samanin R.: Psychopharmacology 94, 84–91 (1988).
Schuurman T., Spencer D.G. and Traber J.: Psychopharmacology 89, S54 (1987).
File S.E.: Neuropsychobiology 13, 55–62 (1985).
Davis M.: Behav. Neurosci. 100, 814–824 (1986).
Joordens R.J.E., Hijzen T.H., Peeters B.W.M.M. and Olivier B.: Psychopharmacology 126, 104–109 (1996).
Joordens R.J.E., Hijzen T.H. and Olivier B.: Psychopharmacology 139, 383–390 (1998).
Hijzen T.H., Houtzager S.W.J., Joordens R.J.E., Olivier B. and Slangen J.L.: Psychopharmacology 118, 150–154 (1995).
Lal H. and Emmett-Oglesby M.W.: Neuropharmacology 22, 1423–1441 (1983).
Stephens D.N. and Andrews J.S., in: P. Willner (ed.): Behavioural Models in Psychopharmacology. Cambridge Univ. Press, Cambridge 1991, 50–75.
De Vry J., Benz U., Schreiber R. and Traber J.: Eur. J. Pharmacol. 249, 331–339 (1993).
Sanchez C.: Behav. Pharmacol. 4, 269–277 (1993).
Kaltwasser M.T.: Behav. Brain Res. 43, 133–137 (1991).
Vivian J.A. and Miczek K.A.: Psychopharmacology 112, 66–73 (1993)
Tornatzky W. and Miczek K.A.: Psychopharmacology 121, 135–144 (1995).
Van der Poel A.M., Noach E.J.K. and Miczek K.A.: Psychopharmacology 97, 147–148 (1989).
Olivier B., Molewijk H., Groenink L., Joordens R., Zethof T. and Mos J., in: H.G.M. Westenberg, J.A. Den Boer and D.L. Murphy (eds.): Advances in the Neurobiology of Anxiety Disorders. John Wiley & Sons, Chichester 1996, 83–105.
Molewijk H.E., Van der Poel A.M., Mos J., Van der Heyden J.A.M. and Olivier B.: Psychopharmacology 117, 32–40 (1995).
Treit D., Pinel J.P.J. and Fibiger H.C.: Pharmacol. Biochem. Behav. 15, 619–626 (1981).
Treit D., in: R.J. Rodgers and S.J. Cooper (eds.): 5-HT1A Agonists, 5-HT3 Antagonists and Benzodiazepines, their Comparative Behavioural Pharmacology. John Wiley & Sons, Chichester 1991, 107–131.
Broekkamp C.L., Rijk H.W., Joly-Gelouin D. and Lloyd K.L.: Eur. J. Pharmacol. 126, 223–229 (1986).
Broekkamp C.L.E., Berendsen H.H.G., Jenck F. and Van Delft A.M.L.: Psychopathology 22 (Suppl. 1), 2–12 (1989).
Kaesermann H.P.: Psychopharmacology 89, 31–37 (1986).
Pollard G.T. and Howard J.C.: Psychopharmacology 94, 433–434 (1988).
Molewijk H.E., Van der Poel A.M. and Olivier B.: Psychopharmacology 121, 81–90 (1995).
Borsini F., Lecci A., Volterra G. and Meli A.: Psychopharmacology 98, 207–211 (1989).
Lecci A., Borsini F., Mancinelli A., D’Arranno V., Stasi A., Voltera G. and Meli A.: J. Neural. Transm. 82, 219–230 (1990).
Zethof T.J.J., Van der Heyden J.A.M. and Olivier B.: Eur. J. Pharmacol. 294, 125–135 (1995).
Van der Heyden J.A.M., Zethof T.J.J. and Olivier B.: Physiol. Behav. 62, 463–470 (1997).
Gardner C.R.: Drug Dev. Res. 5, 185–193 (1985).
Gardner C.R.: J. Pharmacol. Meth. 14, 181–187 (1985).
Winslow J.T. and Insel T.R.: Progr. Neuropsychopharmacol. Biol. Psychiatry 15, 745–757 (1991).
Winslow J.T. and Insel T.R.: Psychopharmacology 105, 513–520 (1991).
Olivier B., Molewijk H.E., Van der Heyden J.A.M., Van Oorschot R., Ronken E., Mos J. and Miczek K.A.: Neurosci. Biobehav. Rev. 23, 215–227 (1998).
Molewijk H.E., Hartog K. and Van der Poel A.M.: Psychopharmacology 128, 28–31 (1996).
Miczek K.A. and Vivian J.A.: Psychopharmacology 110, 379–382 (1993).
Porsolt R.D., Lenègre A. and McArthur R.A., in: B. Olivier, J. Mos and J.L. Slangen (eds.): Animal Models in Psychopharmacology. Birkhäuser Verlag, Basel 1991, 137–159.
Willner P., in: P. Willner (ed.): Behavioural Models in Psychopharmacology, Theoretical, Industrial and Clinical Perspectives. Cambridge Univ. Press, Cambridge 1991, 91–125.
Borsini F. and Meli A.: Psychopharmacology 94, 147–160 (1988).
Van der Heyden J.A.M., Olivier B. and Zethof T.H.H., in: B. Olivier, J. Mos and J.L. Slangen (eds.): Animal Models in Psychopharmacology. Birkhäuser Verlag, Basel 1991, 211–215.
Van der Heyden J.A.M., Molewijk E. and Olivier B.: Psychopharmagology 92, 127–130 (1987).
Seiden L.S., Dahms J.L. and Shaughnessy R.A.: Psychopharmacology 86, 55–60 (1985).
Willner P. and Papp M., in: P. Skolnick (ed.): Antidepressants, New Pharmacological Strategics. Humana Press, Toronto NJ 1997, 213–234.
Cairncross K.D., Cox B., Forster C and Wren A.F.: J. Pharmacol. Meth. 1, 131–143 (1978).
Danysz W., Archer T. and Fowler C., in: P. Willner (ed.): Behavioural Models in Psychopharmacology, Theoretical, Industrial and Clinical Perspectives. Cambridge Univ. Press, Cambridge 1991, 126–156.
Panksepp J., Yates G., Ikemoto S. and Nelson E., in: B. Olivier, J. Mos and J.L. Slangen (eds.): Animal Models in Psychopharmacology. Birkhäuser Verlag, Basel 1991, 161–181.
Pecknold J.C: CNS Drugs 2, 234–251 (1994).
Fulton B. and Brogden R.N.: CNS Drugs 7, 68–88 (1997).
Barradell L.B. and Fitton A.: CNS Drugs 5, 147–153 (1996).
De Vry J.M.: Drug News Persp. 9, 270–280 (1996).
De Vry J.M.: Psychopharmacology 121, 1–16 (1995).
Artigas F., Romero L., De Montigny C. and Blier P.: TINS 19, 378–383 (1996).
Conners C.K., Jackson D.L., Silva D. and March J.: Psychopharmacol Bull 33, 507 (1997).
Geretsegger C., Greimel K.V., Roed LS. and Keppel Hesselink J.M.: Int. J. Eating Disorders 17, 359–363 (1995).
Murasaki M., Mori A., Endo S., Takemasa K. and Hasegawa K.: Rinsho Hyoka 20, 259–293 (1992).
Van Harten J., Bradford L.D. and De Koning P.: EP710481. CA 124, 33311 2a (1996).
7th Eur. Stroke Conf. (Edinborough): Cerebrovasc. Dis. 8 (Suppl. 4) (1998).
Wolff M.C. and Leander J.D.: Eur. J. Pharmacol. 340, 217–220 (1997).
Critchley DJ., Wilson K.M.R. and Middlefell VC: Brit. J. Pharmac. 112 (Suppl.), Abstract 109P (1994).
Ridley R.M., Harder J.A. and Baker H.F.: Neurodegeneration 5, 467–471 (1996).
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1999 Springer Basel AG
About this chapter
Cite this chapter
Olivier, B., Soudijn, W., van Wijngaarden, I. (1999). The 5-HT1A receptor and its ligands: structure and function. In: Jucker, E. (eds) Progress in Drug Research. Progress in Drug Research, vol 52. Birkhäuser, Basel. https://doi.org/10.1007/978-3-0348-8730-4_3
Download citation
DOI: https://doi.org/10.1007/978-3-0348-8730-4_3
Publisher Name: Birkhäuser, Basel
Print ISBN: 978-3-0348-9746-4
Online ISBN: 978-3-0348-8730-4
eBook Packages: Springer Book Archive